Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Century Casinos, Inc. operates as a casino entertainment company in the United States, Canada, and Poland. The company develops and operates gaming establishments, as well as related lodging, restaurant, horse racing, and entertainment facilities. As of March 8, 2022, it operated two ship-based casinos. The company was founded in 1992 and is based in Colorado Springs, Colorado.

Century Casinos, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

COLORADO SPRINGS, COLO., JULY 30, 2026 /PRNEWSWIRE/ -- CENTURY CASINOS, INC. (NASDAQ CAPITAL MARKET: CNTY) ANNOUNCED TODAY THAT THE COMPANY WILL RELEASE ITS EARNINGS FOR THE SECOND QUARTER 2026 ON FRIDAY, AUGUST 7, 2026.

CENTURY CASINOS ANNOUNCES DATES OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

PHILADELPHIA, JULY 09, 2026 (GLOBE NEWSWIRE) -- CENTURY THERAPEUTICS, INC. (CENTURY', NASDAQ: IPSC), A BIOTECHNOLOGY COMPANY DEVELOPING INDUCED PLURIPOTENT STEM CELL (IPSC)-DERIVED CELL THERAPIES FOR AUTOIMMUNE DISEASES, INCLUDING TYPE 1 DIABETES (T1D), AND CANCER, TODAY ANNOUNCED THAT ITS ABSTRACTS HAVE BEEN ACCEPTED FOR ORAL PRESENTATIONS AT TWO UPCOMING SCIENTIFIC CONGRESSES:

CENTURY THERAPEUTICS SELECTED FOR ORAL PRESENTATIONS OF CNTY-813 PRECLINICAL DATA AT EASD 2026 AND BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS 2026

PHILADELPHIA, JUNE 08, 2026 (GLOBE NEWSWIRE) -- CENTURY THERAPEUTICS, INC. (CENTURY', NASDAQ: IPSC), A BIOTECHNOLOGY COMPANY DEVELOPING INDUCED PLURIPOTENT STEM CELL (IPSC)-DERIVED CELL THERAPIES FOR AUTOIMMUNE DISEASES, INCLUDING TYPE 1 DIABETES (T1D), AND CANCER, TODAY ANNOUNCED THE PRESENTATION OF NEW PRECLINICAL DATA FROM CNTY-813, CENTURY'S IPSC-DERIVED ISLET REPLACEMENT THERAPY ENGINEERED WITH ALLO-EVASION 5.0, IN AN ORAL PRESENTATION AT THE AMERICAN DIABETES ASSOCIATION (ADA) 86TH SCIENTIFIC SESSIONS IN NEW ORLEANS, LOUISIANA.

NEW CNTY-813 PRECLINICAL DATA DEMONSTRATE DURABLE GLUCOSE CONTROL, IMMUNE EVASION UNDER ALLOIMMUNE PRESSURE, AND SCALABLE MANUFACTURING AT ADA 2026

COLORADO SPRINGS, COLO., MAY 13, 2026 /PRNEWSWIRE/ -- CENTURY CASINOS, INC. (THE "COMPANY" OR "CENTURY CASINOS") (NASDAQ CAPITAL MARKET: CNTY) ANNOUNCED TODAY THAT LYLE RANDOLPH, A LONG-TERM REGIONAL VICE PRESIDENT AND GENERAL MANAGER OF THE COMPANY, WILL TAKE OVER AS EXECUTIVE VICE PRESIDENT OF OPERATIONS FOR THE UNITED STATES.

CENTURY CASINOS ANNOUNCES APPOINTMENT TO TOP LEADERSHIP ROLE IN THE UNITED STATES

ALL-TIME RECORD FIRST QUARTER NET OPERATING REVENUE COLORADO SPRINGS, COLO., MAY 8, 2026 /PRNEWSWIRE/ -- CENTURY CASINOS, INC. (THE "COMPANY", "WE", "US", OR "OUR") (NASDAQ CAPITAL MARKET: CNTY) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2026.

CENTURY CASINOS, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS

COLORADO SPRINGS, COLO., MAY 1, 2026 /PRNEWSWIRE/ -- CENTURY CASINOS, INC. (NASDAQ CAPITAL MARKET: CNTY) ANNOUNCED TODAY THAT THE COMPANY WILL RELEASE ITS EARNINGS FOR THE FIRST QUARTER 2026 ON FRIDAY, MAY 8, 2026.

CENTURY CASINOS ANNOUNCES DATES OF FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

CNTY-813 IS AN IPSC-DERIVED ISLET CELL REPLACEMENT THERAPY ENGINEERED WITH ALLO-EVASION5.0 FOR PATIENTS WITH TYPE 1 DIABETES; ON TRACK FOR IND SUBMISSION IN 4Q 2026 CNTY-813 IS AN IPSC-DERIVED ISLET CELL REPLACEMENT THERAPY ENGINEERED WITH ALLO-EVASION5.0 FOR PATIENTS WITH TYPE 1 DIABETES; ON TRACK FOR IND SUBMISSION IN 4Q 2026

CENTURY THERAPEUTICS SELECTED FOR ORAL PRESENTATION OF CNTY813 PRECLINICAL DATA AT THE AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

PROMISING START TO 2026 ACROSS ENTIRE NORTH AMERICAN PORTFOLIO COLORADO SPRINGS, COLO., MARCH 13, 2026 /PRNEWSWIRE/ -- CENTURYCASINOS, INC. (THE "COMPANY", "WE", "US", OR "OUR") (NASDAQ CAPITAL MARKET: CNTY) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THREE MONTHS AND YEAR ENDED DECEMBER 31, 2025.

CENTURY CASINOS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS

COLORADO SPRINGS, COLO., MARCH 6, 2026 /PRNEWSWIRE/ -- CENTURY CASINOS, INC. (NASDAQ CAPITAL MARKET: CNTY) ANNOUNCED TODAY THAT THE COMPANY WILL RELEASE ITS EARNINGS FOR THE FOURTH QUARTER AND YEAR END 2025 ON FRIDAY, MARCH 13, 2026.

CENTURY CASINOS ANNOUNCES DATES OF FOURTH QUARTER AND YEAR END 2025 EARNINGS RELEASE AND CONFERENCE CALL

COLORADO SPRINGS, COLO. , DEC. 1, 2025 /PRNEWSWIRE/ -- CENTURY CASINOS, INC. (NASDAQ CAPITAL MARKET: CNTY) ("CENTURY" OR THE "COMPANY") ANNOUNCED TODAY THE OPENING OF THE NEW BETMGM RETAIL SPORTSBOOK AT CENTURY CASINO & HOTEL CAPE GIRARDEAU.

CENTURY CASINOS GOES LIVE WITH ONLINE SPORTS BETTING AND RETAIL SPORTSBOOK AT CENTURY CASINO & HOTEL CAPE GIRARDEAU IN PARTNERSHIP WITH BETMGM IN MISSOURI

Century Casinos, Inc.

CNTY

Price

Financial Reports

No items found.

Press Releases

Century Casinos, Inc.

CNTY.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

CNTY